Sv. Zimmet et al., Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey, J CL PSYCH, 20(1), 2000, pp. 94-98
Substance use disorders, particularly those involving alcohol, marijuana, a
nd cocaine, are highly prevalent among patients with schizophrenia and cont
ribute markedly to its overall morbidity, Unfortunately, standard (typical)
antipsychotic medications do not seem to reduce substance use in patients
with schizophrenia and may even increase it. Recently, however, a few anecd
otal case reports and two previous small "N" surveys have found that clozap
ine, an atypical antipsychotic medication, seems to decrease substance use
in patients treated with this drug for their psychoses. The authors report
data from a retrospective survey of substance use in 58 patients treated wi
th clozapine who had a history of comorbid schizophrenia (or schizoaffectiv
e disorder) and substance use disorder. Of these 58 patients, 43 were being
treated with clozapine at the time of the survey; the remaining 15 patient
s had discontinued clozapine before the survey. The survey involved chart r
eview and clinician interview to assess change in substance use and global
clinical symptoms while receiving treatment with clozapine. More than 85% o
f the patients who were active substance users at the time of initiation of
treatment with clozapine decreased their substance use over the course of
clozapine administration. For patients who continued treatment with clozapi
ne up to the present, the decrease in substance use was strongly correlated
with a decrease in global clinical symptoms. Data from this retrospective
survey further support the previous observations that clozapine reduces sub
stance use among patients with schizophrenic disorders. Moreover, the data
suggest the need for prospective controlled studies of the effects of cloza
pine on substance use in this population.